Stocks and securities in focus
Security ▼ | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Vivoryon Therapeutics N.V. | -2.920% | -11.364% | 11.835% | -82.729% | -73.321% | -88.989% | -65.291% |
Uniqure B.V. | -1.610% | -9.510% | 66.411% | -24.500% | 13.682% | -71.463% | -87.137% |
Twist Bioscience Corp | -19.780% | -26.375% | -10.688% | 101.330% | 13.955% | -60.202% | - |
Savara Inc. | 0.470% | 1.923% | 3.922% | 31.677% | -1.852% | 296.262% | 86.620% |
Sarepta Therapeutics | 0.530% | -1.874% | -6.969% | 38.831% | 50.882% | 130.969% | 1.505% |
Sage Therapeutics Inc. | -0.460% | -7.964% | -12.682% | -73.792% | -55.970% | -75.887% | -93.987% |
Revance Therapeutics Inc. | -2.560% | - | - | - | - | - | - |
Puma Biotechnology Inc. | 10.940% | -0.795% | 21.305% | 7.901% | -10.474% | -47.206% | -56.797% |
Plant Advanced T. | 3.360% | - | - | - | - | - | - |
Ocular Therapeutix Inc. | -3.370% | -8.170% | 14.529% | 81.508% | 69.828% | -24.989% | 61.496% |
MacroGenics Inc. | -6.060% | -31.294% | -12.180% | -21.435% | -61.067% | -83.557% | -73.531% |
Inventiva SA | 1.180% | -2.036% | -22.401% | -39.694% | -47.001% | -81.174% | - |
Insmed Inc. | 1.480% | 0.735% | 11.382% | 244.221% | 139.510% | 242.500% | 340.741% |
ImmunityBio Inc. | -4.090% | -17.009% | -25.573% | 142.034% | -9.237% | -54.513% | 277.445% |
G1 Therapeutics | -6.170% | 0.385% | 72.264% | 87.282% | 32.800% | -74.943% | - |
Fate Therapeutics Inc. | -8.630% | -15.342% | 39.362% | 23.485% | 19.179% | -94.088% | -76.778% |
Evotec SE | -4.330% | -6.786% | -11.806% | -64.730% | -62.055% | -76.494% | -68.065% |
Evolus Inc | 11.500% | 16.667% | 26.633% | 37.705% | 39.227% | 34.759% | - |
Esperion Therapeutis.Inc. | -5.600% | -15.652% | -13.680% | 15.411% | -34.373% | -85.075% | -94.593% |
Enlivex Therapeutics Ltd. | 1.670% | -3.175% | -2.400% | -48.739% | -45.536% | -80.787% | -93.444% |
Eli Lilly Corp. | -4.160% | -0.607% | -12.678% | 77.419% | 39.583% | 254.497% | 628.117% |
DBV Technologies S.A. | -4.100% | -10.696% | 5.263% | -70.847% | -54.617% | -90.326% | -94.819% |
Coherus Bioscien. | -6.020% | -21.368% | -4.351% | -68.676% | -59.145% | -88.811% | -91.917% |
Celsion Corp. | -29.450% | 10.577% | 1.770% | 2.679% | 93.277% | -91.434% | -94.864% |
Cellectar BioSciences Inc. | -3.660% | -13.810% | -18.468% | -7.179% | -20.614% | -80.000% | - |
Carisma Therapeutics Inc. | 1.100% | -4.688% | -39.039% | -81.277% | -65.493% | -98.567% | -95.499% |
Bovie Medical Corp | -3.280% | -7.813% | -0.840% | -75.918% | -50.000% | -83.724% | -81.987% |
Ardelyx Inc. | 7.540% | 7.309% | 12.851% | 50.407% | -3.979% | 293.617% | 152.790% |
Applied Therapeutics Inc | 23.530% | - | - | - | - | - | - |
Alnylam Pharmace. | -0.600% | 15.164% | 8.023% | 45.673% | 40.734% | 66.233% | 255.248% |